BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 7956395)

  • 1. The clinical evaluation for diagnosing obstructive airways disease in high-risk patients.
    Badgett RG; Tanaka DJ; Hunt DK; Jelley MJ; Feinberg LE; Steiner JF; Petty TL
    Chest; 1994 Nov; 106(5):1427-31. PubMed ID: 7956395
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Can moderate chronic obstructive pulmonary disease be diagnosed by historical and physical findings alone?
    Badgett RG; Tanaka DJ; Hunt DK; Jelley MJ; Feinberg LE; Steiner JF; Petty TL
    Am J Med; 1993 Feb; 94(2):188-96. PubMed ID: 8430714
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The accuracy of patient history, wheezing, and laryngeal measurements in diagnosing obstructive airway disease. CARE-COAD1 Group. Clinical Assessment of the Reliability of the Examination-Chronic Obstructive Airways Disease.
    Straus SE; McAlister FA; Sackett DL; Deeks JJ
    JAMA; 2000 Apr; 283(14):1853-7. PubMed ID: 10770147
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The added value of C-reactive protein to clinical signs and symptoms in patients with obstructive airway disease: results of a diagnostic study in primary care.
    Schneider A; Dinant GJ; Maag I; Gantner L; Meyer JF; Szecsenyi J
    BMC Fam Pract; 2006 May; 7():28. PubMed ID: 16670014
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The objective evaluation of obstructive pulmonary diseases with spirometry.
    Ozkaya S; Dirican A; Tuna T
    Int J Chron Obstruct Pulmon Dis; 2016; 11():2009-15. PubMed ID: 27616884
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Paradoxical movement of the lateral rib margin (Hoover sign) for detecting obstructive airway disease.
    Garcia-Pachon E
    Chest; 2002 Aug; 122(2):651-5. PubMed ID: 12171846
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Impact of Using Non-Birth Sex on the Interpretation of Spirometry Data in Subjects With Air-Flow Obstruction.
    Haynes JM; Stumbo RW
    Respir Care; 2018 Feb; 63(2):215-218. PubMed ID: 29184047
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of smokers susceptible to development of chronic airflow limitation: a 13-year follow-up.
    Stănescu D; Sanna A; Veriter C; Robert A
    Chest; 1998 Aug; 114(2):416-25. PubMed ID: 9726724
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Indications for spirometry in outpatients with respiratory disease.
    Owens MW; Anderson WM; George RB
    Chest; 1991 Mar; 99(3):730-4. PubMed ID: 1995230
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A hospital-based study on pulmonary function tests and exercise tolerance in patients of chronic obstructive pulmonary disease and other diseases.
    Majumdar S; Sen S; Mandal SK
    J Indian Med Assoc; 2007 Oct; 105(10):565-6, 568, 570 passim. PubMed ID: 18383952
    [TBL] [Abstract][Full Text] [Related]  

  • 11. FEV1/FEV6 and FEV6 as an alternative for FEV1/FVC and FVC in the spirometric detection of airway obstruction and restriction.
    Vandevoorde J; Verbanck S; Schuermans D; Kartounian J; Vincken W
    Chest; 2005 May; 127(5):1560-4. PubMed ID: 15888828
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhaled corticosteroids in children: use and effects of early treatment on asthma and lung function. Prevalence of asthma and the impact of severity in early life on later asthma in childhood.
    Devulapalli CS
    Clin Respir J; 2008 Oct; 2(4):247-8. PubMed ID: 20298343
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Concave Shape of the Forced Expiratory Flow-Volume Curve in 3 Seconds Is a Practical Surrogate of FEV
    Li H; Liu C; Zhang Y; Xiao W
    Respir Care; 2017 Mar; 62(3):363-369. PubMed ID: 27999150
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical Utility of Additional Measurement of Total Lung Capacity in Diagnosing Obstructive Lung Disease in Subjects With Restrictive Pattern of Spirometry.
    Lee H; Chang B; Kim K; Song WJ; Chon HR; Kang HK; Kim JS; Jeong BH; Oh YM; Koh WJ; Park HY
    Respir Care; 2016 Apr; 61(4):475-82. PubMed ID: 26884447
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Flow Decay: A Novel Spirometric Index to Quantify Dynamic Airway Resistance.
    Oh A; Morris TA; Yoshii IT; Morris TA
    Respir Care; 2017 Jul; 62(7):928-935. PubMed ID: 28559470
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cut-off value of FEV1/FEV6 as a surrogate for FEV1/FVC for detecting airway obstruction in a Korean population.
    Chung KS; Jung JY; Park MS; Kim YS; Kim SK; Chang J; Song JH
    Int J Chron Obstruct Pulmon Dis; 2016; 11():1957-63. PubMed ID: 27578970
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predicting inadequate spirometry technique and the use of FEV1/FEV3 as an alternative to FEV1/FVC for patients with mild cognitive impairment.
    Allen S; Yeung P; Janczewski M; Siddique N
    Clin Respir J; 2008 Oct; 2(4):208-13. PubMed ID: 20298336
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Can peak expiratory flow measurements reliably identify the presence of airway obstruction and bronchodilator response as assessed by FEV(1) in primary care patients presenting with a persistent cough?
    Thiadens HA; De Bock GH; Van Houwelingen JC; Dekker FW; De Waal MW; Springer MP; Postma DS
    Thorax; 1999 Dec; 54(12):1055-60. PubMed ID: 10567623
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Spirometric impairments in long-term insulators. Relationships to duration of exposure, smoking, and radiographic abnormalities.
    Miller A; Lilis R; Godbold J; Chan E; Wu X; Selikoff IJ
    Chest; 1994 Jan; 105(1):175-82. PubMed ID: 8275729
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.